LONDON – Today, in-vitro diagnostics (IVD) presents an essential part of modern healthcare industry. The IVD products (analytical instruments, reagents and accessory products) are extensively utilized for diagnosis, assessment of medical intervention and monitoring of prescribed treatments. Besides, IVD enables earlier and also more targeted treatment, which, in its turn, ensures reduced hospital stays as well as convalescences; thus, resulting in a healthier population and stable economic growth in the long term.

Globally, the IVD market has demonstrated positive performance since 2009. On the basis of technology, the market is dominated by immunoassay and conventional chemistry. Meanwhile, by test location, the market is lead by laboratory test sector, followed by self-test sector. The reagent sector calls for the biggest share of the IVD market on the basis of IVD products.

Enhancing world healthcare expenses, increasing ageing population, rising prevalence of diabetic disorders, growing incidence of infectious and chronic diseases are amid the key forces, driving further positive growth in the worldwide IVD market. The world IVD market is characterized by strong competition amid the players. Abbott, Siemens, Roche and Johnson & Johnson are among the top participants in the world IVD market.

Topical research study “Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition” worked out by Koncept Analytics suggests a comprehensive analysis of the global in-vitro diagnostics (IVD) market development. The report provides a detailed study of the IVD segments and the regional markets; discloses data on the market performance and also highlights the key market trends. Furthermore, the profiles of the most influential companies involved in the industry are available in the report. Besides, the report gives important information on the main market growth drivers, challenges, restraints and opportunities. Additionally, the study comprises a set of forecasts of the global IVD market development.